Zymergen to Present at UBS Global Healthcare Virtual Conference
Rhea-AI Summary
Zymergen, a leader in biofacturing, will participate in the UBS Global Healthcare Virtual Conference on May 26, 2021. The presentation is scheduled for 3:00 p.m. Eastern Time (12:00 p.m. Pacific Time). Interested stakeholders can access a live and archived webcast through the Investors' section of the company's website. Zymergen focuses on designing and manufacturing bio-based products across diverse industries, leveraging a unique blend of biology, chemistry, software, and automation.
Positive
- None.
Negative
- None.
News Market Reaction – ZY
In the trading session that priced this news, ZY declined 2.99%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming UBS Global Healthcare Virtual Conference.
Zymergen’s management is scheduled to present on Wednesday, May 26th at 3:00 p.m. Eastern Time/12:00 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.zymergen.com/.
About Zymergen
Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Investor Contact
Niraj Javeri
investors@zymergen.com
Media Contact
Mike Dulin
mdulin@zymergen.com
502-777-2029